Skip to main content
. 2021 Dec 22;10(1):8. doi: 10.3390/vaccines10010008

Figure 5.

Figure 5

The three-dimensional structure of the protein was predicted by I-TASSER and Discontinuous epitope prediction of the putative epitopes identified by ElliPro (left and with colored epitopes) and DiscoTope (right and epitopes in brown). (A) UDP-N-acetylmuramate dehydrogenase (Orientia tsutsugamushi; WP_011944569.1), (B) Type IV secretion system protein (O. tsutsugamushi; WP_011945117.1), (C) Phospho-N-acetylmuramoyl-pentapeptide-transferase (Borrelia recurrentis; WP_012538808.1), (D) Phospho-N-acetylmuramoyl-pentapeptide-transferase (Rickettsia prowazekii str. Madrid E; NP_220963.1), (E) Phospho-N-acetylmuramoyl-pentapeptide-transferase (O. tsutsugamushi; WP_011944610.1), (F) Type IV secretion system protein (O. tsutsugamushi; WP_011944382.1), (G) phospho-N-acetylmuramoyl-pentapeptide-transferase (Borrelia miyamotoi; WP_020954693.1), (H) flagellar type III secretion system pore protein FliP (B. miyamotoi; WP_020954665.1) and (I) phospho-N-acetylmuramoyl-pentapeptide-transferase (Borreliella mayonii; WP_075552002.1).